Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (2023)
LSFX elicits significant bactericidal effects on cell-internalized GAS, hence it may represent a potent therapeutic option for patients with acute pharyngotonsillitis in whom AMPC treatment has failed.